NL166470C - METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN - Google Patents

METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN

Info

Publication number
NL166470C
NL166470C NL7213959.A NL7213959A NL166470C NL 166470 C NL166470 C NL 166470C NL 7213959 A NL7213959 A NL 7213959A NL 166470 C NL166470 C NL 166470C
Authority
NL
Netherlands
Prior art keywords
preparing
stominic
removering
bronchi
dissolution
Prior art date
Application number
NL7213959.A
Other languages
Dutch (nl)
Other versions
NL166470B (en
NL7213959A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7213959A publication Critical patent/NL7213959A/xx
Priority to NLAANVRAGE8100488,A priority Critical patent/NL172654C/en
Publication of NL166470B publication Critical patent/NL166470B/en
Application granted granted Critical
Publication of NL166470C publication Critical patent/NL166470C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL7213959.A 1971-10-29 1972-10-16 METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN NL166470C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE8100488,A NL172654C (en) 1971-10-29 1981-02-02 METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVING ACTION, METHOD FOR PREPARING PYRIMIDINE COMPOUNDS USED THEREIN, AND FORMED MEDICINAL PRODUCT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (3)

Publication Number Publication Date
NL7213959A NL7213959A (en) 1973-05-02
NL166470B NL166470B (en) 1981-03-16
NL166470C true NL166470C (en) 1981-08-17

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7213959.A NL166470C (en) 1971-10-29 1972-10-16 METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT321308B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH549579A (en)
DE (3) DE2264657C2 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377308A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL84634B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
JPS5752409Y2 (en) * 1979-11-05 1982-11-15
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
CA2620065C (en) 2005-08-22 2011-03-29 Melior Discovery, Inc. Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
BR112019021140A2 (en) 2017-04-10 2020-05-19 Univ Louisiana State composition, method to reduce blood glucose levels, weight gain or fat deposit levels, or treatment, adipocyte beige induction method or preventing pancreatic beta cell degeneration, and lyn kinase activator and agonist of trpm8 for use in reducing blood glucose levels, weight gain or fat deposit levels, or treatment.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
PL84634B1 (en) 1976-04-30
SU498908A3 (en) 1976-01-05
NO136574B (en) 1977-06-20
YU36295B (en) 1982-06-18
IE37043B1 (en) 1977-04-27
DE2264374C3 (en) 1981-07-23
EG11013A (en) 1976-11-30
DK131465B (en) 1975-07-21
FI55503C (en) 1979-08-10
NO136574C (en) 1977-09-28
IL48790A0 (en) 1976-03-31
DK131465C (en) 1975-12-08
PH10129A (en) 1976-09-02
JPS5337870B2 (en) 1978-10-12
IL40458A (en) 1976-05-31
IL40458A0 (en) 1972-11-28
FR2157865B1 (en) 1975-10-31
CH549579A (en) 1974-05-31
AR198798A1 (en) 1974-07-24
NL166470B (en) 1981-03-16
DE2264657C2 (en) 1982-09-16
JPS53116386A (en) 1978-10-11
FR2157865A1 (en) 1973-06-08
IE37043L (en) 1973-04-29
AU467600B2 (en) 1975-12-04
YU35125B (en) 1980-09-25
DE2264374A1 (en) 1973-05-24
LU66304A1 (en) 1973-05-03
PH11594A (en) 1978-03-31
DE2248741A1 (en) 1973-05-03
AR196263A1 (en) 1973-12-10
SE397090B (en) 1977-10-17
CH555832A (en) 1974-11-15
DE2264657A1 (en) 1974-06-20
DE2248741B2 (en) 1974-11-14
SE7505279L (en) 1975-05-06
JPS5422995B2 (en) 1979-08-10
NL7213959A (en) 1973-05-02
CA980778A (en) 1975-12-30
DE2248741C3 (en) 1975-06-26
FI55503B (en) 1979-04-30
ES436624A1 (en) 1977-02-01
IL48790A (en) 1976-05-31
AT321308B (en) 1975-03-25
JPS4852780A (en) 1973-07-24
AT320656B (en) 1975-02-25
SE393376B (en) 1977-05-09
GB1377720A (en) 1974-12-18
ZA727362B (en) 1973-11-28
GB1377308A (en) 1974-12-11
BE790125A (en) 1973-04-16
SU505362A3 (en) 1976-02-28
ES407730A1 (en) 1976-01-16
PL89852B1 (en) 1976-12-31
YU255172A (en) 1980-03-15
AU4722872A (en) 1974-04-04
DE2264374B2 (en) 1980-08-07
YU99179A (en) 1981-08-31

Similar Documents

Publication Publication Date Title
NL170143C (en) PROCESS FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-IGNITION ACTIVITY, AND METHOD FOR PREPARING POLYARYLIMIDAZOLES SUITABLE FOR IT.
NL170147C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION, FORMED PREPARATION THEREOF AND HETEROCYCLIC DIAMINES FOR THIS
NL182806C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH A BLOOD-IMPROVING AND BRONCHOSPASMOLYTIC ACTION, FORMED MEDICINAL PRODUCT AND A METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL178965C (en) METHOD FOR THE PREPARATION OF MEDICINAL PRODUCTS WITH BETA-ADRENOLYTIC ACTION, FORMED MEDICINAL PRODUCTS CONTAINING THEM AND METHOD FOR PREPARING COMPOUNDS WITH THIS ACTION
NL179583C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION, AND PROCESS FOR PREPARING MEDICINAL AROYL SUBSTITUTED PENYLACACIC ACID DERIVATIVES.
NL177386B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-ALLERGIC ACTION
NL176072C (en) PROCESS FOR THE PREPARATION OF 2-ALKYL 5-THIAZOLIC CARBONIC ACID ESTERS, AND A MEDICINAL PRODUCT WITH DEVASTATIC ACTION; FORMED MEDICINAL PRODUCT.
NL166470C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVERING AND THE DISSOLUTION OF STOMINIC ACID AGAINST ACTION, AND METHOD FOR PREPARING PYRIMIDIN COMPOUNDS USED THEREIN
NL173400C (en) A PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON 2-SUBSTITUTED-5-SULFAMYLBENOIC ACIDS AND A METHOD FOR THE PRODUCTION OF 2-SUBSTITUTED-5-SULFAMYLBENOIC ACIDS.
NL176460B (en) PROCESS FOR THE PREPARATION AND PRODUCTION OF A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING USE THEREOF TRIAZOLODIAZEPINE COMPOUNDS.
NL161444C (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ARRHYTMIC ACTION, FORMED MEDICINAL PRODUCT WITH SUCH ACTION AND PROCESS FOR THE PREPARATION OF A UREA DERIVATIVE.
NL170529C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION BASED ON A 3-ALKOXY-1-ARYLOXYPROPANOL-2 AND METHOD FOR PREPARING THE COMPOUNDS TO BE USED THEREOF
NL180665C (en) PROCESS FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND A METHOD FOR PREPARING A 7-ACYLAMINO-3-HETEROCYCLYLTHIOMETHYL-3-CEPHAMIC CARBONIC ACID.
NL7416163A (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANTI-EMETIC, STOMACH-DEFLY STIMULATING ETC. ACTION, A MEDICINAL PRODUCT WITH SUCH ACTION AND A METHOD FOR THE PREPARATION OF MEDICINAL COMPOUNDS.
NL176173C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANALGETIC AND ANTI-INFLAMMATORIC ACTION AND THE USE THEREOF NEW AROYL-THIOPHENE-ACETIC ACID DERIVATIVES.
CH550220A (en) POLYMERIZABLE MIXTURE AND PROCESS FOR THE PREPARATION.
NL179580C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTIARYTHMIC ACTION, FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING USEFUL MEDICINE IMIDAZOLINE DERIVATIVES
NL164474C (en) METHOD FOR THE PREPARATION OF A BACTERICIDE IODINE PREPARATION, AND AN USE SOLUTION THEREOF
NL156129B (en) PROCESS FOR THE PREPARATION OF A PREPARATION WITH ANTI-INFLAMMATORY AND ANALGETIC ACTION, A MEDICINAL PRODUCT WITH SUCH ACTION AND A PROCESS FOR THE PREPARATION OF CORE SUBSTITUTED 3-ALKOXYPHENYLACIC ACIDS.
NL183763C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY EFFECT, AND METHOD FOR PREPARING 3,20-DIOXO-4-PREGNINE COMPOUNDS
NL153774B (en) PROCESS FOR THE PREPARATION OF INDOLYL-PYRIDYL KETONE CONTAINING PREPARATIONS WITH IGNITION-SUPPRESSING ACTION, AND TABLETS AND / OR PROPOSETS SO OBTAINED.
NL7408875A (en) PROCESS FOR THE PREPARATION OF ALKALIPOLYPHOSPHATE COMPLEXES WITH ANTIBIOTIC ACTION, PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND SUCH MEDICINAL PRODUCT.
NL169179C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ADRENERGICALLY STIMULATING EFFECT, FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING UREIDOBENZYL COMPOUNDS
NL160565C (en) PROCESS FOR PREPARING A PREPARATION WITH ANALGETICAL ACTION, FORMED PREPARATION AND PROCESS FOR PREPARING MEDICINAL COMPOUNDS.
NL172654C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BRONCHI-REMOVING ACTION, METHOD FOR PREPARING PYRIMIDINE COMPOUNDS USED THEREIN, AND FORMED MEDICINAL PRODUCT

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee